JOIN THE CONVERSATION!

Dr. Donald S. Clem discusses his groundbreaking clinical study: Harvest graft substitute for soft tissue volume augmentation around existing implants (Clem et al., J Periodontol, 2023). This randomized, controlled, and blinded multicenter trial compares Geistlich Fibro-Gide®—a volume-stable collagen matrix—to the gold standard connective tissue graft (CTG) for soft tissue volume augmentation around dental implants.

Dr. Mark Spilker, the Chief Scientific Officer of Geistlich Pharma AG, brings knowledge and experience from his previous role at MTF Biologics. The conversation centers around the partnership between Geistlich and MTF, focusing on transitioning into the allograft space, the significance of MTF’s high-quality tissue, and the differences between aseptic processing and terminal sterilization in allograft use.

This video is an engaging discussion on soft tissue regeneration. Dr. Lorenzo Tavelli and Dr. Shayan Barootchi delve into their groundbreaking research on root coverage procedures. Their study focuses on the effectiveness of using a Geistlich Fibro-Gide® along with PDGF (recombinant human platelet-derived growth factor-BB) in enhancing healing and stability in gum grafting.

Listen in for an insightful conversation with Dr. Robert Levine as he talks about regeneration and his experience with Geistlich Fibro-Gide®. From his go-to handling techniques to real clinical cases, Dr. Levine shares practical tips and expert insights you won’t want to miss.

Join us for an insightful interview with Dr. Tara Aghaloo, Oral and Maxillofacial Surgeon, as she shares her experience with growth factors—specifically recombinant human PDGF (rhPDGF). Dr. Aghaloo discusses clinical outcomes, when she believes rhPDGF has the most impact, and how she sees the future of growth factors evolving in surgical practice.

In this episode of Talkin’ Bout Regeneration, Dr. Matteo Chiapasco shares his extensive experience with Yxoss CBR®, a titanium mesh used in dental regeneration. He discusses the importance of patient selection, managing mesh exposures, and the evolution of Yxoss CBR® designs. Dr. Chiapasco emphasizes that while exposures can occur, they do not signify failure and offers practical advice for surgeons to ensure successful outcomes.